X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2805) 2805
Book Review (257) 257
Publication (110) 110
Magazine Article (9) 9
Conference Proceeding (5) 5
Book Chapter (3) 3
Newsletter (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2579) 2579
humans (2481) 2481
ethambutol - therapeutic use (1976) 1976
rifampin - therapeutic use (1353) 1353
male (1341) 1341
female (1285) 1285
isoniazid - therapeutic use (1198) 1198
antitubercular agents - therapeutic use (1161) 1161
adult (1143) 1143
tuberculosis, pulmonary - drug therapy (1056) 1056
middle aged (932) 932
drug therapy, combination (746) 746
tuberculosis (681) 681
ethambutol (666) 666
aged (550) 550
pyrazinamide - therapeutic use (533) 533
streptomycin - therapeutic use (464) 464
adolescent (452) 452
tuberculosis - drug therapy (432) 432
ethambutol - administration & dosage (421) 421
infectious diseases (419) 419
mycobacterium tuberculosis - drug effects (379) 379
abridged index medicus (376) 376
rifampin - administration & dosage (326) 326
microbiology (311) 311
treatment outcome (309) 309
ethambutol - adverse effects (297) 297
rifampin (288) 288
time factors (285) 285
microbial sensitivity tests (276) 276
drug resistance, microbial (275) 275
pharmacology & pharmacy (274) 274
isoniazid - administration & dosage (269) 269
antitubercular agents - administration & dosage (260) 260
child (252) 252
mycobacterium tuberculosis - isolation & purification (236) 236
anti-bacterial agents - therapeutic use (233) 233
respiratory system (232) 232
animals (225) 225
antitubercular agents - pharmacology (216) 216
sputum - microbiology (216) 216
antitubercular agents - adverse effects (214) 214
drug resistance (209) 209
isoniazid (207) 207
ethambutol - pharmacology (202) 202
pyrazinamide (192) 192
pulmonary tuberculosis (189) 189
rifampin - adverse effects (189) 189
mycobacterium tuberculosis (182) 182
tuberculosis, pulmonary - microbiology (181) 181
mycobacterium avium-intracellulare infection - drug therapy (179) 179
mycobacterium-tuberculosis (177) 177
clarithromycin - therapeutic use (172) 172
drug therapy (170) 170
aids/hiv (157) 157
tuberculosis, multidrug-resistant - drug therapy (154) 154
rifampin - pharmacology (152) 152
follow-up studies (147) 147
isoniazid - adverse effects (144) 144
child, preschool (143) 143
immunology (143) 143
retrospective studies (141) 141
drugs (139) 139
medicine, general & internal (138) 138
mice (138) 138
isoniazid - pharmacology (135) 135
aminosalicylic acids - therapeutic use (134) 134
antibiotics, antitubercular - therapeutic use (134) 134
clarithromycin (134) 134
pyrazinamide - administration & dosage (133) 133
infection (132) 132
radiography (132) 132
drug combinations (127) 127
clinical trials as topic (126) 126
antitubercular agents (125) 125
young adult (123) 123
recurrence (121) 121
diagnosis (119) 119
rifampicin (118) 118
infections (116) 116
tuberculosis, pulmonary - diagnosis (115) 115
drug administration schedule (110) 110
chronic disease (109) 109
drug synergism (108) 108
therapy (108) 108
mycobacterium infections, nontuberculous - drug therapy (107) 107
mycobacterium tuberculosis - genetics (107) 107
chemotherapy (106) 106
diagnosis, differential (106) 106
tuberculosis, pulmonary - complications (106) 106
analysis (105) 105
aids (103) 103
ethionamide - therapeutic use (103) 103
mycobacterium avium complex (103) 103
aids-related opportunistic infections - drug therapy (102) 102
infant (102) 102
research (101) 101
health aspects (98) 98
pharmacokinetics (93) 93
aged, 80 and over (92) 92
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2063) 2063
French (174) 174
German (149) 149
Russian (94) 94
Italian (74) 74
Polish (59) 59
Spanish (54) 54
Japanese (47) 47
Romanian (31) 31
Chinese (14) 14
Croatian (10) 10
Norwegian (6) 6
Turkish (6) 6
Dutch (5) 5
Portuguese (5) 5
Swedish (5) 5
Danish (3) 3
Finnish (3) 3
Korean (3) 3
Serbian (3) 3
Czech (2) 2
Hebrew (2) 2
Hungarian (2) 2
Ukrainian (2) 2
Lithuanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 17, Issue 1, pp. 39 - 49
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9979, pp. 1738 - 1747
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1588 - 1598
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1577 - 1587
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1599 - 1608
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9670, pp. 1183 - 1189
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 1/2013, Volume 207, Issue 1, pp. 9 - 17
Background. Extensively drug-resistant tuberculosis (XDR-tuberculosis) is a global public health threat, but few data exist elucidating factors driving this... 
Epidemics | Ferries | BACTERIA | Tuberculosis | Disease transmission | Mycobacterium tuberculosis | HIV | Hospital admissions | Data transmission | Multidrug resistant tuberculosis | Infection control | Genotyping | Drug resistance | Transmission | MYCOBACTERIUM-TUBERCULOSIS | INFECTIOUS DISEASES | tuberculosis | genotyping | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | CARE | transmission | NEW-YORK-CITY | INFECTED PATIENTS | drug resistance | XDR-TB | OUTBREAK | SPREAD | STRAIN | EPIDEMIOLOGY | Prevalence | Humans | Male | Cross Infection - complications | Cross Infection - transmission | Adult | Extensively Drug-Resistant Tuberculosis - microbiology | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Ethambutol - therapeutic use | Antitubercular Agents - therapeutic use | Cross Infection - epidemiology | Extensively Drug-Resistant Tuberculosis - complications | Mycobacterium tuberculosis - classification | HIV Infections - virology | South Africa - epidemiology | Genotype | Sequence Analysis, DNA | Mycobacterium tuberculosis - isolation & purification | Pyrazinamide - therapeutic use | Extensively Drug-Resistant Tuberculosis - epidemiology | Hospitals, Rural | Polymorphism, Restriction Fragment Length | Extensively Drug-Resistant Tuberculosis - transmission | Cross Infection - microbiology | HIV Infections - complications | Mutation | Cluster Analysis | Mycobacterium tuberculosis - genetics | Extensively drug-resistant tuberculosis | Distribution | Reports | Cross infection | Research | Nosocomial infections | Risk factors | Index Medicus | Abridged Index Medicus | Major and Brief Reports
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 01/2015, Volume 191, Issue 1, pp. 96 - 103
Journal Article